
Trong Q. Phan
Examiner (ID: 496, Phone: (571)272-1794 , Office: P/2825 )
| Most Active Art Unit | 2818 |
| Art Unit(s) | 2504, 2818, 2825, 2824, 2899, 2827, 2511 |
| Total Applications | 3077 |
| Issued Applications | 2717 |
| Pending Applications | 50 |
| Abandoned Applications | 311 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16541369
[patent_doc_number] => 20200407782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => METHODS OF DETECTING NUCLEIC ACIDS IN INDIVIDUAL CELLS AND OF IDENTIFYING RARE CELLS FROM LARGE HETEROGENEOUS CELL POPULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/012394
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012394
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/012394 | METHODS OF DETECTING NUCLEIC ACIDS IN INDIVIDUAL CELLS AND OF IDENTIFYING RARE CELLS FROM LARGE HETEROGENEOUS CELL POPULATIONS | Sep 3, 2020 | Abandoned |
Array
(
[id] => 17853120
[patent_doc_number] => 20220283162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => MCM5 ELISA FOR THE DETECTION OF RECURRENT BLADDER CANCER
[patent_app_type] => utility
[patent_app_number] => 17/634579
[patent_app_country] => US
[patent_app_date] => 2020-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634579
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/634579 | MCM5 ELISA FOR THE DETECTION OF RECURRENT BLADDER CANCER | Aug 31, 2020 | Abandoned |
Array
(
[id] => 18666580
[patent_doc_number] => 11773458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Compositions and methods for detection of BK virus
[patent_app_type] => utility
[patent_app_number] => 17/005779
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12147
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 425
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17005779
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/005779 | Compositions and methods for detection of BK virus | Aug 27, 2020 | Issued |
Array
(
[id] => 17883093
[patent_doc_number] => 20220298570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => OPTIMIZED NUCLEIC ACID PROBES FOR ANALYTE DETECTION
[patent_app_type] => utility
[patent_app_number] => 17/636403
[patent_app_country] => US
[patent_app_date] => 2020-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17636403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/636403 | OPTIMIZED NUCLEIC ACID PROBES FOR ANALYTE DETECTION | Aug 19, 2020 | Abandoned |
Array
(
[id] => 16629042
[patent_doc_number] => 20210047695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => CANCER TREATMENTS AND METHODS OF SELECTING SAME
[patent_app_type] => utility
[patent_app_number] => 16/998690
[patent_app_country] => US
[patent_app_date] => 2020-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16998690
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/998690 | CANCER TREATMENTS AND METHODS OF SELECTING SAME | Aug 19, 2020 | Abandoned |
Array
(
[id] => 16614036
[patent_doc_number] => 20210032689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations
[patent_app_type] => utility
[patent_app_number] => 16/996180
[patent_app_country] => US
[patent_app_date] => 2020-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16996180
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/996180 | Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations | Aug 17, 2020 | Abandoned |
Array
(
[id] => 16571084
[patent_doc_number] => 20210010090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => METHOD AND SYSTEM FOR PREDICTING RECURRENCE AND NON-RECURRENCE OF MELANOMA USING SENTINEL LYMPH NODE BIOMARKERS
[patent_app_type] => utility
[patent_app_number] => 16/986324
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17545
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16986324
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/986324 | METHOD AND SYSTEM FOR PREDICTING RECURRENCE AND NON-RECURRENCE OF MELANOMA USING SENTINEL LYMPH NODE BIOMARKERS | Aug 5, 2020 | Abandoned |
Array
(
[id] => 16688777
[patent_doc_number] => 20210071253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => HERITABLE EPIGENETIC MODIFICATIONS AS MARKERS OF CHEMOTHERAPY EXPOSURE
[patent_app_type] => utility
[patent_app_number] => 16/939287
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14272
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16939287
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/939287 | HERITABLE EPIGENETIC MODIFICATIONS AS MARKERS OF CHEMOTHERAPY EXPOSURE | Jul 26, 2020 | Abandoned |
Array
(
[id] => 17274838
[patent_doc_number] => 20210381036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => METHODS AND COMPOSITION FOR HIGH THROUGHPUT SINGLE MOLECULE PROTEIN DETECTION SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/938746
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938746
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/938746 | METHODS AND COMPOSITION FOR HIGH THROUGHPUT SINGLE MOLECULE PROTEIN DETECTION SYSTEMS | Jul 23, 2020 | Abandoned |
Array
(
[id] => 16673507
[patent_doc_number] => 20210062270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => OLIGONUCLEOTIDE PROBES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/936618
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 115349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16936618
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/936618 | OLIGONUCLEOTIDE PROBES AND USES THEREOF | Jul 22, 2020 | Pending |
Array
(
[id] => 16555649
[patent_doc_number] => 20210000797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => MOLECULAR GENETIC APPROACH TO TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG DEPENDENCE
[patent_app_type] => utility
[patent_app_number] => 16/931813
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18013
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16931813
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/931813 | Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence | Jul 16, 2020 | Issued |
Array
(
[id] => 17355339
[patent_doc_number] => 20220016135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => TREATING BREAST CANCER WITH HORMONE RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/931303
[patent_app_country] => US
[patent_app_date] => 2020-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22825
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16931303
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/931303 | TREATING BREAST CANCER WITH HORMONE RECEPTOR MODULATORS | Jul 15, 2020 | Abandoned |
Array
(
[id] => 16598083
[patent_doc_number] => 20210024614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification
[patent_app_type] => utility
[patent_app_number] => 16/927641
[patent_app_country] => US
[patent_app_date] => 2020-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27384
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16927641
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/927641 | Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification | Jul 12, 2020 | Pending |
Array
(
[id] => 16399208
[patent_doc_number] => 20200340066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => DIAGNOSING IDH1 RELATED SUBGROUPS AND TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/923803
[patent_app_country] => US
[patent_app_date] => 2020-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51238
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16923803
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/923803 | DIAGNOSING IDH1 RELATED SUBGROUPS AND TREATMENT OF CANCER | Jul 7, 2020 | Abandoned |
Array
(
[id] => 16557570
[patent_doc_number] => 20210002718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => QUANTITATIVE MICROBIAL COMMUNITY PROFILING USING MOLECULAR INVERSION PROBES WITH UNIQUE MOLECULAR IDENTIFIERS
[patent_app_type] => utility
[patent_app_number] => 16/918093
[patent_app_country] => US
[patent_app_date] => 2020-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16918093
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/918093 | QUANTITATIVE MICROBIAL COMMUNITY PROFILING USING MOLECULAR INVERSION PROBES WITH UNIQUE MOLECULAR IDENTIFIERS | Jun 30, 2020 | Abandoned |
Array
(
[id] => 16689666
[patent_doc_number] => 20210072143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => HIGH CAPACITY MOLECULE DETECTION
[patent_app_type] => utility
[patent_app_number] => 16/918958
[patent_app_country] => US
[patent_app_date] => 2020-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16918958
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/918958 | HIGH CAPACITY MOLECULE DETECTION | Jun 30, 2020 | Pending |
Array
(
[id] => 16598452
[patent_doc_number] => 20210024983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => NUCLEIC ACID ANALYSIS METHOD AND APPARATUS
[patent_app_type] => utility
[patent_app_number] => 16/918499
[patent_app_country] => US
[patent_app_date] => 2020-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4822
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16918499
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/918499 | NUCLEIC ACID ANALYSIS METHOD AND APPARATUS | Jun 30, 2020 | Pending |
Array
(
[id] => 18005392
[patent_doc_number] => 20220364158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => METHODS AND DEVICES FOR IDENTIFYING PATHOGENS AND ANTIBODIES AND TREATMENT DEVICE THEREFORE
[patent_app_type] => utility
[patent_app_number] => 17/621989
[patent_app_country] => US
[patent_app_date] => 2020-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -64
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17621989
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/621989 | METHODS AND DEVICES FOR IDENTIFYING PATHOGENS AND ANTIBODIES AND TREATMENT DEVICE THEREFORE | Jun 24, 2020 | Abandoned |
Array
(
[id] => 16361435
[patent_doc_number] => 20200318186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => Nucleic Acid Probe and Method of Detecting Genomic Fragments
[patent_app_type] => utility
[patent_app_number] => 16/912469
[patent_app_country] => US
[patent_app_date] => 2020-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23604
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16912469
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/912469 | Nucleic Acid Probe and Method of Detecting Genomic Fragments | Jun 24, 2020 | Pending |
Array
(
[id] => 16525597
[patent_doc_number] => 20200399677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => METHODS FOR DIFFERENTIALLY QUANTIFYING NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 16/911268
[patent_app_country] => US
[patent_app_date] => 2020-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16911268
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/911268 | METHODS FOR DIFFERENTIALLY QUANTIFYING NUCLEIC ACIDS | Jun 23, 2020 | Abandoned |